Skip to main content
Clinical Trials/JPRN-UMIN000000802
JPRN-UMIN000000802
Completed
Phase 2

Assessment of the Efficacy of Preoperative Exemestane Therapy for Endocrine-sensitive Postmenopausal Breast Cancer (SBCCSG-10) - Assessment of the Efficacy of Preoperative Exemestane Therapy for Endocrine-sensitive Postmenopausal Breast Cancer (SBCCSG-10)

Saitama Breast Cancer Clinical Study Group (SBCCSG)0 sites23 target enrollmentAugust 18, 2007

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Saitama Breast Cancer Clinical Study Group (SBCCSG)
Enrollment
23
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 18, 2007
End Date
August 1, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Saitama Breast Cancer Clinical Study Group (SBCCSG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients under chemotherapy and hormone therapy (for tumors) 2\.Patients under treatment with the drugs (including HRT) that may influence on the conditions of sex hormone 3\.Patients with a past history of breast cancer or with double cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials